Lung Biopsy Systems Market is likely to register CAGR of 9.4% through 2032

The global lung biopsy systems market is anticipated to be worth US$ 8.6 billion in 2032, growing at a CAGR of 9.4% between 2022 and 2032. Because of the growing preference for less invasive surgeries, demand for lung biopsy devices is expected to rise rapidly in the coming years. According to FMI, the lung biopsy systems market is expected to be worth US$ 3.1 billion in 2022.

As per comprehensive research conducted by ESOMAR-certified consulting firm FMI, the global Lung Biopsy Systems market is projected to witness robust growth during the forecast year 2022 to 2032. The report emphasizes on providing key insights into diverse features including demand, product developments, revenue generation, and sales in the Lung Biopsy Systems market.

Get a PDF Sample with Latest Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-9349

Advent of Telehealth and Virtual Care to Create Tailwind for the Lung Biopsy Systems Market Growth

Digitization is making deeper inroads across diverse industries, such as healthcare, owing to the increasing penetration of the internet and smartphones across the world.

During the COVID-19 outbreak, healthcare practitioners and patients realized the importance of digitization and encouraged them to adopt virtual methods of patient examination and consultation to counter the regulations concerning social distancing. This gave rise to a new medical domain, Telehealth.

Since the outbreak, telehealth has gained immense popularity, especially among the geriatric population, owing to the convenience associated with it. Hence, increasing adoption of telehealth across radiology, behavioral health, cardiology, and online consultation is expected to create lucrative opportunities for growth in the Lung Biopsy Systems market.

Key Lung Biopsy Systems Market Takeaways and Projections

• The US is estimated to continue dominating the North America market, projecting fastest growth in the region through 2032.
• Germany Lung Biopsy Systems market is forecast to register robust growth in Europe, accounting for a significant share in the region between 2022 to 2032.
• China is expected to account for the maximum revenue share in the East Asia market, exhibiting the fastest sales growth during the assessment period.
• India is forecast to emerge as a highly remunerative market in South Asia, contributing for the largest sales in the region over the coming 10-years.

Contact Us for a Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-9349

Report Benefits & Key Questions Answered

• Lung Biopsy Systems Historical Market Outlook: Future Market Insight’s analysis examines vital dynamics, such as drivers, opportunities, and challenges in the Lung Biopsy Systems market. It also studies the impact of these dynamics on the market for the previous assessment period 2017 to 2021 to forecast the scope of market growth over the coming forecast period 2022 to 2032.
• Lung Biopsy Systems Demand-Supply Assessment: The latest study published by FMI offers in-depth insights into governing factors facilitating the demand outlook of the Lung Biopsy Systems market. As per the survey, Lung Biopsy Systems sales will project steady growth over the forecast period.
• Lung Biopsy Systems Market Structure Analysis: The report provides detailed information about market the concentration of key players and tier analysis in the Lung Biopsy Systems market. It also categories market players as per Tier 1, Tier 2, and Tier 3 in terms of their percentage share and product portfolio.
• Lung Biopsy Systems Market Trend Analysis: FMI’s market trend analysis provide compelling insights into current and upcoming trends in the healthcare industries. It also assists the industry players to identify potential trends to formulate a strategy to take advantage of these existing trends.

Competitive Landscape Analysis

The latest study conducted by FMI provides in-depth insights into the global Lung Biopsy Systems market to assist management level decision-makers in constructing a strategy to capitalize on the critical trends & opportunities. It also discloses competitive trends and profiles a list of leading players operating in the global Lung Biopsy Systems market.

Some of the prominent market players are profiled by FMI are:

• Fujifilm Medical Systems
• DTR Medical
• BD
• Olympus Corporation
• Medtronic
• Hologic, Inc.
• B. Braun Melsungen AG
• Cardinal Health
• Argon Medical Devices

Request Customization of Report@ https://www.futuremarketinsights.com/customization-available/rep-gb-9349

Key Segments Profiled in the Lung Biopsy Systems Industry Survey

By Product Type:

• Core Needle Biopsy Devices
• Fine Needle Aspiration Biopsy Devices
• Surgical Biopsy Devices
• Vacuum-Assisted Biopsy Devices

By Procedure Type:

• Needle Biopsy
• Thoracoscopic Biopsy
• Transbronchial Biopsy
• Open Biopsy

By End Use:

• Hospitals
• Cancer Research Centers
• Specialty Clinics
• Others

Region

• North America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa